Unfallkrankenhaus Berlin
10
2
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Preventing Recurrences of Chronic Subdural Hematoma in Adult Patients by Middle Meningeal Artery Embolization
Role: lead
Hierarchy of Effects of Laboratory Markers and Their Interaction With Comorbidity Concerning Outcome and Personalized Treatment of Trauma Patients in Emergency Care and Rehabilitation
Role: collaborator
Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture
Role: collaborator
Autoimmunity And Immune Deficiency After Spinal Cord Injury: Association With Rehabilitation Outcomes
Role: collaborator
Berlin - SPecific Acute Treatment in Ischemic or hAemorrhagic Stroke With Long Term Follow-up
Role: collaborator
Electrical Stimulation in Traumatic Brain Injury (TBI) Induced Aphasia
Role: collaborator
Abdominal Wall Repair With Strattice in Germany: a Cohort Study
Role: collaborator
Intensive Faciltiation of Swallowing in Patients With Severe Dysphagia After Acquired Brain Injury
Role: collaborator
Healing of Burns and the Effect of Shockwave Therapy on the Recovery of Skin Grafts
Role: lead
European Study on Prediction of Outcome in Patients With Idiopathic Normal Pressure Hydrocephalus
Role: collaborator
All 10 trials loaded